Brand name
Tudriqev, the original
We didn’t find a savings card or cash price from Tudriqev’s maker. Ask the pharmacy for Tudriqev’s cash price. With insurance, ask what your plan charges.
Generic name: vusolimogene oderparepvec-wtpg
Used for: Advanced melanoma of the skin
Ask for the cash price
Tudriqev
Tudriqev is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.
Tudriqev, the original
We didn’t find a savings card or cash price from Tudriqev’s maker. Ask the pharmacy for Tudriqev’s cash price. With insurance, ask what your plan charges.
There isn’t one.
Tudriqev is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.
TUDRIQEV is a genetically modified oncolytic viral therapy indicated in combination with nivolumab for the treatment of adult patients with unresectable advanced cutaneous melanoma who experienced disease progression with a programmed death receptor-1 (PD-1)-blocking antibody-based regimen.
This indication is approved under accelerated approval based on objective response rate (ORR) and duration of response. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s).
Source: the FDA label for Tudriqev (Replimune, Inc.), August 17, 2026. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/tudriqev/